The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Toxic epidermal necrolysis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nagata, S. (1997) · Cell · doi:10.1016/s0092-8674(00)81874-7 · Cited by 4,938
A marker for Stevens–Johnson syndrome
Chung, W.-H., Hung, S.-I., Hong, H.-S., Hsih, M.-S., Yang, L.-C., Ho, H.-C., Wu, J.-Y., & Chen, Y.-T. (2004) · Nature · doi:10.1038/428486a · Cited by 1,753
Bastuji‐Garin, S. (1993) · Archives of Dermatology · doi:10.1001/archderm.129.1.92 · Cited by 1,697
Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis
Roujeau, J.-C., Kelly, J. P., Naldi, L., Rzany, B., Stern, R. S., Anderson, T., Auquier, A., Bastuji-Garin, S., Correia, O., Locati, F., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332404 · Cited by 1,465
Mallal, S., Nolan, D., Witt, C., Masel, G., Martin, A., Moore, C., Sayer, D., Castley, A., Mamotte, C., Maxwell, D., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07873-x · Cited by 1,380
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
Hung, S.-I., Chung, W.-H., Liou, L.-B., Chu, C.-C., Lin, M., Huang, H.-P., Lin, Y.-L., Lan, J.-L., Yang, L.-C., Hong, H.-S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409500102 · Cited by 1,284
Mockenhaupt, M., Viboud, C., Dunant, A., Naldi, L., Halevy, S., Bavinck, J. N. B., Sidoroff, A., Schneck, J., Roujeau, J.-C., & Flahault, A. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701033 · Cited by 1,017
Inhibition of Toxic Epidermal Necrolysis by Blockade of CD95 with Human Intravenous Immunoglobulin
Viard, I., Wehrli, P., Bullani, R., Schneider, P., Holler, N., Salomon, D., Hunziker, T., Saurat, J.-H., Tschopp, J., & French, L. E. (1998) · Science · doi:10.1126/science.282.5388.490 · Cited by 1,005
HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
McCormack, M., Alfirevic, A., Bourgeois, S., Farrell, J. J., Kasperavičiūtė, D., Carrington, M., Sills, G. J., Marson, T., Jia, X., de Bakker, P. I. W., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013297 · Cited by 925
Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin
(1999) · Transfusion Medicine Reviews · doi:10.1016/s0887-7963(99)80071-6 · Cited by 869
Chung, W.-H., Hung, S.-I., Yang, J.-Y., Su, S.-C., Huang, S.-P., Wei, C.-Y., Chin, S.-W., Chiou, C.-C., Chu, S.-C., Ho, H.-C., et al. (2008) · Nature Medicine · doi:10.1038/nm.1884 · Cited by 840
Genetic variations in HLA-B region and hypersensitivity reactions to abacavir
Hetherington, S., Hughes, A. R., Mosteller, M., Shortino, D., Baker, K. L., Spreen, W., Lai, E., Davies, K., Handley, A., Dow, D. J., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08158-8 · Cited by 807
Sassolas, B., Haddad, C., Mockenhaupt, M., Dunant, A., Liss, Y., Bork, K., Haustein, U. F., Vieluf, D., Roujeau, J. C., & Le Louet, H. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.252 · Cited by 758
TOXIC EPIDERMAL NECROLYSIS: AN ERUPTION RESEMBLING SCALDING OF THE SKIN.
LYELL, A. (1956) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1956.tb12766.x · Cited by 720
Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B
Darmon, A. J., Nicholson, D. W., & Bleackley, R. C. (1995) · Nature · doi:10.1038/377446a0 · Cited by 707
Toxic epidermal necrolysis and Stevens-Johnson syndrome
Harr, T., & French, L. E. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-39 · Cited by 693
Lonjou, C., Borot, N., Sekula, P., Ledger, N., Thomas, L., Halevy, S., Naldi, L., Bouwes-Bavinck, J.-N., Sidoroff, A., de Toma, C., et al. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282f3ef9c · Cited by 624
Man, C. B. L., Kwan, P., Baum, L., Yu, E., Lau, K. M., Cheng, A. S. H., & Ng, M. H. L. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01022.x · Cited by 507
Hematology: basic principles and practice
Goldman, J. (2013) · Bone Marrow Transplantation · doi:10.1038/bmt.2013.77 · Cited by 495
Locharernkul, C., Loplumlert, J., Limotai, C., Korkij, W., Desudchit, T., Tongkobpetch, S., Kangwanshiratada, O., Hirankarn, N., Suphapeetiporn, K., & Shotelersuk, V. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01719.x · Cited by 482
Nitric oxide and its role in apoptosis
Brüne, B., von Knethen, A., & Sandau, K. B. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00274-x · Cited by 445
Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis
Wolkenstein, P., Latarjet, J., Roujeau, J.-C., Duguet, C., Boudeau, S., Vaillant, L., Maignan, M., Schuhmacher, M.-H., Milpied, B., Pilorget, A., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)02197-7 · Cited by 428
Toxic epidermal necrolysis: Effector cells are drug-specific cytotoxic T cells
Nassif, A., Bensussan, A., Boumsell, L., Deniaud, A., Moslehi, H., Wolkenstein, P., Bagot, M., & Roujeau, J.-C. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.07.047 · Cited by 412
Kaniwa, N., Saito, Y., Aihara, M., Matsunaga, K., Tohkin, M., Kurose, K., Sawada, J.-I., Furuya, H., Takahashi, Y., Muramatsu, M., et al. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.11.1617 · Cited by 410
A marker for Stevens-Johnson syndrome …: ethnicity matters
Lonjou, C., Thomas, L., Borot, N., Ledger, N., de Toma, C., LeLouet, H., Graf, E., Schumacher, M., Hovnanian, A., Mockenhaupt, M., et al. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500356 · Cited by 401
Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome: An Epidemiologic Study From West Germany
Schöpf, E. (1991) · Archives of Dermatology · doi:10.1001/archderm.1991.01680050083008 · Cited by 399
Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients
Revuz, J. E. (1987) · Archives of Dermatology · doi:10.1001/archderm.123.9.1160 · Cited by 395
Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981-1985
Roujeau, J. (1990) · Archives of Dermatology · doi:10.1001/archderm.126.1.37 · Cited by 391
Pereira, F. A., Mudgil, A. V., & Rosmarin, D. M. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.04.048 · Cited by 376
Chan, H.-L. (1990) · Archives of Dermatology · doi:10.1001/archderm.1990.01670250049006 · Cited by 371
Rzany, B., Mockenhaupt, M., Baur, S., Schröder, W., Stocker, U., Mueller, J., Holländer, N., Bruppacher, R., & Schöpf, E. (1996) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(96)00035-2 · Cited by 355
Rzany, B., Correia, O., Kelly, J. P., Naldi, L., Auquier, A., & Stern, R. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05418-x · Cited by 348
The current understanding of Stevens–Johnson syndrome and toxic epidermal necrolysis
Mockenhaupt, M. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.11.66 · Cited by 347
Chessman, D., Kostenko, L., Lethborg, T., Purcell, A. W., Williamson, N. A., Chen, Z., Kjer-Nielsen, L., Mifsud, N. A., Tait, B. D., Holdsworth, R., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.04.020 · Cited by 334
Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature
Letko, E., Papaliodis, D. N., Papaliodis, G. N., Daoud, Y. J., Ahmed, A. R., & Foster, C. S. (2005) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)61112-x · Cited by 316
Drug Specific Cytotoxic T-Cells in the Skin Lesions of a Patient with Toxic Epidermal Necrolysis
Nassif, A., Bensussan, A., Bachot, N., Bagot, M., Boumsell, L., Roujeau, J.-C., Dorothée, G., & Mami-Chouaib, F. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01622.x · Cited by 310
Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis
PAUL, C., WOLKENSTEIN, P., ADLE, H., WECHSLER, J., GARCHON, H. J., REVUZ, J., & ROUJEAU, J. C. (1996) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1996.tb06976.x · Cited by 304
Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome Are Induced by Soluble Fas Ligand
Abe, R., Shimizu, T., Shibaki, A., Nakamura, H., Watanabe, H., & Shimizu, H. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64284-8 · Cited by 301
The Culprit Drugs in 87 Cases of Toxic Epidermal Necrolysis (Lyell's Syndrome)
Guillaume, J. C. (1987) · Archives of Dermatology · doi:10.1001/archderm.123.9.1166 · Cited by 257
Posadas, S. J., Padial, A., Torres, M. J., Mayorga, C., Leyva, L., Sanchez, E., Alvarez, J., Romano, A., Juarez, C., & Blanca, M. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.120563 · Cited by 252
Toxic epidermal necrolysis: current evidence, practical management and future directions
Chave, T. A., Mortimer, N. J., Sladden, M. J., Hall, A. P., & Hutchinson, P. E. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06721.x · Cited by 241
Schnyder, B., Burkhart, C., Schnyder-Frutig, K., von Greyerz, S., Naisbitt, D. J., Pirmohamed, M., Park, B. K., & Pichler, W. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6647 · Cited by 211
Biology and clinical relevance of granulysin
Krensky, A. M., & Clayberger, C. (2009) · Tissue Antigens · doi:10.1111/j.1399-0039.2008.01218.x · Cited by 203
Immune pathomechanism of drug hypersensitivity reactions
Pichler, W. J., Naisbitt, D. J., & Park, B. K. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.048 · Cited by 189
Roujeau, J. (1997) · The Journal of Dermatology · doi:10.1111/j.1346-8138.1997.tb02524.x · Cited by 188
Acute disseminated epidermal necrosis types 1, 2, and 3: Study of sixty cases
Ruiz-Maldonado, R. (1985) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(85)70207-1 · Cited by 164
Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis
Paquet, P. (1994) · Archives of Dermatology · doi:10.1001/archderm.130.5.605 · Cited by 157
Viard, I., Gaide, O., Jankovic, D. L., Feldmeyer, L., Kerl, K., Pickard, C., Roques, S., Friedmann, P. S., Contassot, E., & French, L. E. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.330 · Cited by 143
Stimulation of human T cells with sulfonamides and sulfonamide metabolites
Castrejón-Flores, J. L., Berry, N. G., El-Ghaiesh, S. H., Gerber, B. O., Pichler, W. J., Park, B. K., & Naisbitt, D. J. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.10.031 · Cited by 139
T-Cell Subsets in Drug-Induced Toxic Epidermal Necrolysis
Miyauchi, H. (1991) · Archives of Dermatology · doi:10.1001/archderm.1991.01680050095011 · Cited by 122
Macrophages and Tumor Necrosis Factor a in Toxic Epidermal Necrolysis
Paquet, P. (1994) · Archives of Dermatology · doi:10.1001/archderm.1994.01690050073012 · Cited by 110
Using a claims database to investigate drug‐induced Stevens‐Johnson syndrome
Strom, B. L., Carson, J. L., Halpern, A. C., Schinnar, R., Snyder, E., Stolley, P. D., Shaw, M., Tilson, H. H., Joseph, M., Dai, W. S., et al. (1991) · Statistics in Medicine · doi:10.1002/sim.4780100408 · Cited by 94
Mycoplasma pneumoniae infections in children.
Stevens, D., Swift, P. G. F., Johnston, P. G. B., Kearney, P. J., Corner, B., & Burman, D. (1978) · Archives of Disease in Childhood · doi:10.1136/adc.53.1.38 · Cited by 90
Ball, R., Ball, L. K., Wise, R. P., Braun, M. M., Beeler, J. A., & Salive, M. E. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200102000-00022 · Cited by 84
Immunoregulatory Effector Cells in Drug-Induced Toxic Epidermal Necrolysis
Paquet, P., Paquet, F., Saleh, W. A., Reper, P., Vanderkelen, A., & Pierard, G. (2000) · American Journal of Dermatopathology · doi:10.1097/00000372-200010000-00005 · Cited by 83
Kashiwagi, M., Aihara, M., Takahashi, Y., YAMAZAKI, E., YAMANE, Y., Song, Y., Muramatsu, M., & Ikezawa, Z. (2008) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2008.00548.x · Cited by 75
Stur, K., Karlhofer, F. M., & Stingl, G. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700648 · Cited by 75
Acute Renal Failure and Its Risk Factors in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Hung, C., Liu, W., Kuo, M., Lee, C., Hwang, S., & Chen, H. (2009) · American Journal of Nephrology · doi:10.1159/000195632 · Cited by 63
Nitric Oxide Synthase in Toxic Epidermal Necrolysis and Stevens–Johnson Syndrome
Lerner, L. H., Qureshi, A. A., Reddy, B. V., & Lerner, E. A. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00816.x · Cited by 62
Caproni, M., Torchia, D., Schincaglia, E., Volpi, W., Frezzolini, A., Schena, D., Marzano, A. V., Quaglino, P., SIMONE, C. D., Parodi, A., et al. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.07023.x · Cited by 58
Paquet, P., & Pierard, G. (2010) · Drug Safety · doi:10.2165/11532540-000000000-00000 · Cited by 56
Engler, O. B., Strasser, I., Naisbitt, D. J., Cerny, A., & Pichler, W. J. (2004) · Toxicology · doi:10.1016/j.tox.2003.12.008 · Cited by 54
Novel Treatments for Drug-Induced Toxic Epidermal Necrolysis (Lyell’s Syndrome)
Paquet, P., Pierard, G., & Quatresooz, P. (2005) · International Archives of Allergy and Immunology · doi:10.1159/000083947 · Cited by 52
Tohyama, M., Watanabe, H., Murakami, S., Shirakata, Y., Sayama, K., Iijima, M., & Hashimoto, K. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10649.x · Cited by 40
Toxic epidermal necrolysis following morbilli‐parotitis‐rubella vaccination
Dobrosavljević, D., Milinkovic, M. V., & Nikolic, M. M. (1999) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.1999.tb00846.x · Cited by 33
Overview and Compartmentalization of the Immune System
Rao, D. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35762-3.00019-6 · Cited by 8
Cited by
Overlapping DRESS and Stevens-Johnson Syndrome: Case Report and Review of the Literature
Casagranda, A., Suppa, M., Dehavay, F., & del Marmol, V. (2017) · Case Reports in Dermatology · doi:10.1159/000475802 · Cited by 1,466
Features and outcomes of 899 patients with drug-induced liver injury: the DILIN Prospective Study
Chalasani, N., Bonkovsky, H. L., Fontana, R., Lee, W., Stolz, A., Talwalkar, J., Reddy, K. R., Watkins, P. B., Navarro, V., Barnhart, H., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.006 · Cited by 925
Creamer, D., Walsh, S. A., Dziewulski, P., Exton, L. S., Lee, H. Y., Dart, J. K. G., Setterfield, J., Bunker, C. B., Ardern‐Jones, M. R., Watson, K. M. T., et al. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14530 · Cited by 277
(2023) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2023.07.001 · Cited by 25
Metadata
- Authors
- Schwartz, R. A., McDonough, P. H., & Lee, B. W.
- Venue
- Journal of the American Academy of Dermatology
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 69
- Issue
- 2
- Pages
- 173.e1-173.e13
- ISSN
- 0190-9622 (ISSN-L)
- OpenAlex
- W2590829207
- Cited by
- 316
- References
- 66
- FWCI
- 22.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.